You are here:
Over the next five years, the interdisciplinary NEUROCOV consortium will investigate the role of the host-virus interplay in the occurrence of neurological and psychiatric symptoms resulting from COVID-19 as a foundation for new treatment options.
Diabetes research: At this year's congress of the European Association for the Study of Diabetes (EASD), Helmholtz Munich scientists received several awards for pioneering ideas and ways to fight the disease.
Helmholtz Munich has been participating in the DigiMed Bayern project of the Bavarian State Ministry of Health and Care (STMGP) since the end of 2018. The goal of the project is to advance digitized medicine in Bavaria. The project has now been…
Dr. Sarah Kim-Hellmuth, Research Group Leader at the Helmholtz Munich Institute of Translational Genomics will be awarded the Friedmund Neumann Prize 2022 for her groundbreaking work in studying the genetic influence on human gene activity.
Prof. Dr. Anette-Gabriele Ziegler, Director of the Helmholtz Munich Institute of Diabetes Research (IDF) receives this year’s EASD–Novo Nordisk Foundation Diabetes Prize for Excellence. The prize is awarded to honor outstanding contributions to the…
How can we predict the distribution of inhaled medical substances on the human body? And how can we do so with alternative methods without animal testing?
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here: